BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 32408568)

  • 1. Comprehensive Mining and Characterization of CRISPR-Cas Systems in
    Pan M; Nethery MA; Hidalgo-Cantabrana C; Barrangou R
    Microorganisms; 2020 May; 8(5):. PubMed ID: 32408568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Occurrence and Diversity of CRISPR-Cas Systems in the Genus Bifidobacterium.
    Briner AE; Lugli GA; Milani C; Duranti S; Turroni F; Gueimonde M; Margolles A; van Sinderen D; Ventura M; Barrangou R
    PLoS One; 2015; 10(7):e0133661. PubMed ID: 26230606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survey of clustered regularly interspaced short palindromic repeats and their associated Cas proteins (CRISPR/Cas) systems in multiple sequenced strains of Klebsiella pneumoniae.
    Ostria-Hernández ML; Sánchez-Vallejo CJ; Ibarra JA; Castro-Escarpulli G
    BMC Res Notes; 2015 Aug; 8():332. PubMed ID: 26238567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of CRISPR-Cas systems in
    Han X; Zhou X; Pei Z; Stanton C; Ross RP; Zhao J; Zhang H; Yang B; Chen W
    Microb Genom; 2022 Apr; 8(4):. PubMed ID: 35451949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [CRISPR/Cas systems in genome engineering of bacteriophages].
    Liang CJ; Meng FM; Ai YC
    Yi Chuan; 2018 May; 40(5):378-389. PubMed ID: 29785946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization and distribution of CRISPR-Cas systems in Lactobacillus sakei.
    Schuster JA; Vogel RF; Ehrmann MA
    Arch Microbiol; 2019 Apr; 201(3):337-347. PubMed ID: 30635671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome Mining Approach Reveals the Occurrence and Diversity Pattern of Clustered Regularly Interspaced Short Palindromic Repeats/CRISPR-Associated Systems in
    Panahi B; Majidi M; Hejazi MA
    Front Microbiol; 2022; 13():911706. PubMed ID: 35722276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization and comparison of CRISPR Loci in Streptococcus thermophilus.
    Hu T; Cui Y; Qu X
    Arch Microbiol; 2020 May; 202(4):695-710. PubMed ID: 31781808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization and applications of Type I CRISPR-Cas systems.
    Hidalgo-Cantabrana C; Barrangou R
    Biochem Soc Trans; 2020 Feb; 48(1):15-23. PubMed ID: 31922192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioinformatics Identification of Anti-CRISPR Loci by Using Homology, Guilt-by-Association, and CRISPR Self-Targeting Spacer Approaches.
    Yin Y; Yang B; Entwistle S
    mSystems; 2019 Sep; 4(5):. PubMed ID: 31506266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The CRISPR-Cas system - from bacterial immunity to genome engineering.
    Czarnek M; Bereta J
    Postepy Hig Med Dosw (Online); 2016 Sep; 70(0):901-16. PubMed ID: 27594566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diversity of CRISPR/Cas system in Clostridium perfringens.
    Long J; Xu Y; Ou L; Yang H; Xi Y; Chen S; Duan G
    Mol Genet Genomics; 2019 Oct; 294(5):1263-1275. PubMed ID: 31134321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the Origin of Reverse Transcriptase-Using CRISPR-Cas Systems and Their Hyperdiverse, Enigmatic Spacer Repertoires.
    Silas S; Makarova KS; Shmakov S; Páez-Espino D; Mohr G; Liu Y; Davison M; Roux S; Krishnamurthy SR; Fu BXH; Hansen LL; Wang D; Sullivan MB; Millard A; Clokie MR; Bhaya D; Lambowitz AM; Kyrpides NC; Koonin EV; Fire AZ
    mBio; 2017 Jul; 8(4):. PubMed ID: 28698278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potent Cas9 Inhibition in Bacterial and Human Cells by AcrIIC4 and AcrIIC5 Anti-CRISPR Proteins.
    Lee J; Mir A; Edraki A; Garcia B; Amrani N; Lou HE; Gainetdinov I; Pawluk A; Ibraheim R; Gao XD; Liu P; Davidson AR; Maxwell KL; Sontheimer EJ
    mBio; 2018 Dec; 9(6):. PubMed ID: 30514786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A genomic sequence of the type II-A clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated system in
    Mizuki H; Shimoyama Y; Ishikawa T; Sasaki M
    J Oral Microbiol; 2022; 14(1):2008153. PubMed ID: 34992734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR-Cas systems and RNA-guided interference.
    Barrangou R
    Wiley Interdiscip Rev RNA; 2013; 4(3):267-78. PubMed ID: 23520078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of Probiotic Bacteria Genomes: Comparison of CRISPR/Cas Systems and Spacer Acquisition Diversity.
    Kahraman Ilıkkan Ö
    Indian J Microbiol; 2022 Mar; 62(1):40-46. PubMed ID: 35068602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occurrence and activity of a type II CRISPR-Cas system in Lactobacillus gasseri.
    Sanozky-Dawes R; Selle K; O'Flaherty S; Klaenhammer T; Barrangou R
    Microbiology (Reading); 2015 Sep; 161(9):1752-1761. PubMed ID: 26297561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR-Cas systems and diversity of targeting phages in Lactobacillus johnsonii strains; insights from genome mining approach.
    Nami Y; Rostampour M; Panahi B
    Infect Genet Evol; 2023 Oct; 114():105500. PubMed ID: 37703922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extending CRISPR-Cas9 Technology from Genome Editing to Transcriptional Engineering in the Genus Clostridium.
    Bruder MR; Pyne ME; Moo-Young M; Chung DA; Chou CP
    Appl Environ Microbiol; 2016 Oct; 82(20):6109-6119. PubMed ID: 27496775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.